GRAIL (GRAL) Projected to Post Earnings on Wednesday

GRAIL (NASDAQ:GRALGet Free Report) is expected to be releasing its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect GRAIL to announce earnings of ($2.66) per share and revenue of $42.39 million for the quarter. Interested persons can check the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:30 PM ET.

GRAIL (NASDAQ:GRALGet Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported ($2.29) EPS for the quarter, beating analysts’ consensus estimates of ($2.76) by $0.47. GRAIL had a negative return on equity of 16.42% and a negative net margin of 253.22%.The business had revenue of $40.78 million during the quarter, compared to the consensus estimate of $39.16 million. On average, analysts expect GRAIL to post $-11 EPS for the current fiscal year and $-11 EPS for the next fiscal year.

GRAIL Stock Performance

NASDAQ GRAL traded up $1.04 during trading hours on Tuesday, hitting $71.31. 143,141 shares of the company’s stock were exchanged, compared to its average volume of 929,435. The business’s 50 day moving average is $66.84 and its 200-day moving average is $67.10. GRAIL has a 12-month low of $29.95 and a 12-month high of $118.84. The firm has a market capitalization of $3.06 billion, a P/E ratio of -6.87 and a beta of 3.24.

GRAIL News Roundup

Here are the key news stories impacting GRAIL this week:

  • Neutral Sentiment: Multiple firms, including Portnoy Law, Gross Law and Hagens Berman, reiterated that investors who purchased GRAIL securities from May 13, 2025, through February 19, 2026, may seek appointment as lead plaintiff by August 4. The notices do not provide materially new allegations beyond the previously filed lawsuit. Portnoy Law Firm Announces Class Action on Behalf of Grail, Inc. Investors
  • Negative Sentiment: The class action alleges that GRAIL and certain executives violated federal securities laws, including Sections 10(b) and 20(a) and Rule 10b-5. If the case advances, GRAIL could face litigation expenses, potential damages and reputational pressure. The allegations have not been proven. Bronstein, Gewirtz & Grossman Class Action Announcement
  • Negative Sentiment: Additional firms, including Faruqi & Faruqi, Berger Montague, Robbins Geller, SBS, DJS and Rosen, urged investors with losses to contact them regarding the lawsuit. The unusually high number of near-identical solicitations increases visibility around the legal issue, but does not itself indicate a new claim or a change in GRAIL’s business outlook. Faruqi & Faruqi Shareholder Action Reminder

Wall Street Analyst Weigh In

GRAL has been the subject of a number of recent analyst reports. TD Cowen restated a “buy” rating on shares of GRAIL in a report on Wednesday, July 15th. The Goldman Sachs Group assumed coverage on shares of GRAIL in a research note on Friday, June 5th. They set a “neutral” rating and a $60.00 price target on the stock. Robert W. Baird set a $70.00 price target on shares of GRAIL in a report on Wednesday, May 6th. Wolfe Research initiated coverage on shares of GRAIL in a research note on Tuesday, June 2nd. They set a “peer perform” rating for the company. Finally, Mizuho upped their price objective on GRAIL from $58.00 to $65.00 and gave the stock a “neutral” rating in a report on Wednesday, July 15th. Four analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $67.78.

Read Our Latest Report on GRAIL

Insider Transactions at GRAIL

In related news, insider Andrew John Partridge sold 1,491 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $61.08, for a total value of $91,070.28. Following the transaction, the insider owned 163,738 shares in the company, valued at approximately $10,001,117.04. This trade represents a 0.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.83% of the company’s stock.

Hedge Funds Weigh In On GRAIL

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Rossby Financial LCC increased its stake in shares of GRAIL by 25.0% in the fourth quarter. Rossby Financial LCC now owns 1,250 shares of the company’s stock worth $107,000 after buying an additional 250 shares during the last quarter. Focus Partners Advisor Solutions LLC acquired a new position in GRAIL during the 4th quarter worth $207,000. Parallel Advisors LLC increased its position in shares of GRAIL by 9.6% in the 3rd quarter. Parallel Advisors LLC now owns 2,534 shares of the company’s stock worth $150,000 after purchasing an additional 221 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in shares of GRAIL by 120.8% in the 2nd quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the company’s stock valued at $129,000 after purchasing an additional 1,375 shares in the last quarter. Finally, HUB Investment Partners LLC bought a new position in shares of GRAIL during the second quarter worth about $201,000.

GRAIL Company Profile

(Get Free Report)

GRAIL, Inc (NASDAQ: GRAL) is a biotechnology company dedicated to the early detection of cancer through a multi-cancer blood test. Leveraging advances in next-generation sequencing, cell-free DNA (cfDNA) analysis and machine learning, GRAIL has developed the Galleri™ test, which aims to identify more than 50 types of cancer at their earliest stages. The company’s platform analyzes methylation patterns in circulating tumor DNA to pinpoint tumor presence and tissue of origin, enabling physicians to pursue timely diagnostic follow-up.

Founded in 2016 as a spin-out from Illumina, GRAIL established its headquarters in Menlo Park, California, with additional research and operations centers in the United Kingdom.

Featured Stories

Earnings History for GRAIL (NASDAQ:GRAL)

Receive News & Ratings for GRAIL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GRAIL and related companies with MarketBeat.com's FREE daily email newsletter.